Top Performing Stocks To Watch For 2014

Red Hat Inc (NYSE:RHT) will announce its fourth quarter and full fiscal year 2014 results on Thursday, March 27, 2014. The company will discuss the operating performance and outlook on the conference call beginning at�5:00 p.m. ET�on the same day.

Red Hat is one of the world's leading providers of open source software solutions, using a community-powered approach to reliable and high-performing cloud, Linux, middleware, storage and virtualization technologies.

Wall Street expects Red Hat to earn 37 cents a share, according to analysts polled by Thomson Reuters. The consensus estimate, which remained flat in the past three months, implies an increase of 2.8 percent from 36 cents a share earned in the same quarter last year. Red Hat expects earnings of 36 to 38 cents a share for the fourth quarter.

Top 5 Services Stocks To Buy Right Now: Dyax Corp.(DYAX)

Dyax Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel biotherapeutics for unmet medical needs in the United States. The company utilizes its proprietary drug discovery technology, known as phage display, to identify antibody, small protein, and peptide compounds. It markets KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. Dyax Corp. also provides KALBITOR Access program, which offers treatment support service for patients with HAE and their healthcare providers. In addition, the company is developing a pipeline of 17 product candidates, including 4 product candidates in Phase III clinical trial, 4 product candidates in Phase II clinical trial, and 9 product candidates in Phase 1 clinical trial for the treatment of atherosclerosis, multiple sclerosis, and oncology diseases. Further, it provides library licenses to use its phage display libr aries in connection with their internal therapeutic development programs; performs funded research for various collaborators; and offers patent licenses to other biopharmaceutical and pharmaceutical companies to use its phage display patents to discover and develop biologic compounds for use in specified fields. The company has strategic partnership agreement with Defiante Farmaceutica S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia; an agreement with CMIC Co., Ltd to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other angioedema indications in Japan; and an license and collaboration agreement with Cubist Pharmaceuticals, Inc. to develop and commercialize the formulation of ecallantide for the reduction of blood loss during surgery in North America and Europe. Dyax Corp. was founded in 1989 and is headquartered in Cambri dge, Massachusetts.

Advisors' Opinion:

• [By Travis Hoium]

  What: Shares of Dyax (NASDAQ: DYAX  ) lost 34% of their value today, falling off a cliff after first-quarter earnings came out.

  So what: First-quarter net sales increased slightly from a year ago, to $12.0 million, but analysts expected $16.0 million in revenue, so this is a huge miss. It's no wonder that net loss of $11.2 million equates to $0.11 per share, more than double the $0.05 per share loss analysts expected.�

Top Performing Stocks To Watch For 2014: Time Warner Inc.(TWX)

Time Warner Inc. operates as a media and entertainment company in the United States and internationally. It operates in three segments: Networks, Filmed Entertainment, and Publishing. The Networks segment provides domestic and international networks, premium pay and basic tier television programming services, and digital media properties, which primarily consist of brand-aligned Websites. Its premium pay television services consist of the multi-channel HBO and Cinemax premium pay television services. This segment provides programming to cable system operators, satellite service distributors, telephone companies, and other distributors; sells advertising; and licenses original programming to domestic and international television networks. The Filmed Entertainment segment produces and distributes feature films, television and other programming, and videogames; distributes home video products; and licenses rights to its feature films, television programming, and characters. T he Publishing segment publishes magazines and books; and operates various Websites, as well as engages in marketing services and direct-marketing businesses. This segment publishes magazines on style and entertainment, lifestyle, news, and sports. The company?s brands include TNT, TBS, CNN, HBO, Cinemax, Warner Bros., New Line Cinema, People, Sports Illustrated, and Time. Time Warner Inc. was founded in 1985 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Garrett Cook]

  Twenty-First Century Fox (NASDAQ: FOXA) shares were also up, gaining 4.95 percent to $32.85 after the company announced Tuesday that it is withdrawing its bid for Time Warner (NYSE: TWX). Instead, the company’s board authorized a $6 billion share repurchase program.

• [By Helix Investment Research]

  We note that Keating Capital's co-investors in many of its portfolio companies are not simply other venture capital or existing investors, but strategic investors as well. Examples include Agilyx, where Waste Management (WM) is a co-investor, BrightSource, where Chevron (CVX) and BP (BP) are co-investors, Kabam, where Google (GOOG) and Intel (INTC) are co-investors, or Tremor Video (TRMR), where Time Warner (TWX) is a co-investor. As of the end of Q2 2013, 9 (excluding Jumptap) of Keating Capital's portfolio companies had unrealized gains, with an average gain of 25.6% (again excluding Jumptap, which had unrealized gains of 8% as of the end of Q2 2013). The remaining 6 companies had an average loss of 44.46%. However, on an overall basis, Keating Capital's portfolio currently has an average unrealized gain of 2.15%. While this is not a large gain, we note that the bulk of Keating Capital's profits are realized upon exiting an investment in conjunction with the portfolio company's IPO or sale. Furthermore, portions of Keating Capital's portfolio are defended by structurally protected appreciation clauses that the company has struck with its portfolio companies, clauses that are not reflected on its balance sheet. These clauses, which are negotiated between Keating Capital and its portfolio companies, allow the company to receive shares in the portfolio company's IPO at a discount, or grant it warrants to purchase additional shares in an IPO for a nominal price. Since inception, Keating Capital has negotiated structurally protected appreciation clauses in 11 of the 20 companies it has invested in. As of the end of Q2 2013, 6 of Keating Capital's 15 portfolio companies were protected by structurally protected appreciation clauses, representing $22 million in total capital (almost 43% of the company's invested capital), thereby entitling Keating Capital to a weighted-average aggregate value of 1.9x its investment at the time of an IPO.

• [By Eric Bleeker, CFA]

  Time Warner's (NYSE: TWX  ) �Man of Steel�slid 65% back to $41 million this weekend, but still remains a success story for the studio. The key area of focus this weekend was international markets. The film kept expanding, and through just two weekends has $188 million in international markets.�

Top Performing Stocks To Watch For 2014: Washington Banking Company(WBCO)

Washington Banking Company operates as the bank holding company for Whidbey Island Bank that provides community commercial banking services in northwestern Washington. Its deposit products include interest-bearing demand and money market accounts, saving deposits, time deposits, NOW accounts, and noninterest-bearing demand deposits. The company?s portfolio of loans comprises secured and unsecured commercial loans for working capital and expansion; real estate mortgage loans, including one-to-four family residential and commercial real estate loans; and real estate construction loans, such as commercial real estate, one-to-four family residential construction, and speculative construction loans. Its consumer loan portfolio include automobile loans, boat and recreational vehicle financing, home equity and home improvement loans, and other secured and unsecured personal loans, as well as SBA guaranteed loans for small and medium sized businesses. In addition, the company pro vides non-deposit managed investment products and services, and sweep investment options. As of December 31, 2010, it operated 30 branches in 6 counties located in northwestern Washington. The company was founded in 1996 and is based in Oak Harbor, Washington.

Advisors' Opinion:

• [By Eric Volkman]

  Washington Banking (NASDAQ: WBCO  ) is diverting some of its capital to repurchase its own stock. The company announced that its board has authorized a buyback program for up to 775,000 shares. The program is expected to continue through the end of 2014, although the firm stressed that it "is under no obligation to repurchase a specific number or dollar amount of shares and the repurchase program may be discontinued at any time."

Top Performing Stocks To Watch For 2014: Hardinge Inc.(HDNG)

Hardinge Inc., together with its subsidiaries, designs, manufactures, and distributes machine tools in North America, Europe, Asia, internationally. It offers high-precision computer-numerically controlled cutting lathes, machining centers, grinding machines, collets, chucks, index fixtures, and other industrial products, as well as related accessories, including work holding, tool holding, and other industrial support products for companies making parts from hard to machine materials, and small and medium-sized independent job shops. The company also offers post-sale support services, including operation and maintenance training, in-field maintenance, and in-field repair. Its metal-cutting turning machines or lathes are used to remove materials from bar stock or a rough-formed part by moving multiple cutting tools against the surface of a part rotating at high speeds in a spindle mechanism; grinding machines are used to finish parts of various shapes and sizes; and machin ing centers are used to remove materials from stationary, prismatic, or box-like parts of various shapes. Hardinge Inc. serves aerospace, automotive, communications, computer, construction equipment, defense, energy, farm equipment, medical equipment, recreational equipment, and transportation industries. It sells its products through distributors, agents, and manufacturers? representatives. The company was founded in 1890 and is headquartered in Elmira, New York.

Advisors' Opinion:

• [By John Emerson]

  Hardinge (HDNG) the Perfect Fit to the Investment Puzzle
  
  Several years earlier I had started following the machine tool sector and I became quite familiar with Hardinge. Although I never invested in the stock (I had opted for Hurco), I had noted that Jeffrey Gendell had been purchasing shares the company. Hurco (HURC) had much higher margins and it was my belief that the superior quality of their computerized machine tools and their accompanying software were reflected in their earnings. Hurco also held a vastly superior balance sheet at the time I made my investment.

Top Performing Stocks To Watch For 2014: Uroplasty Inc (UPI)

Uroplasty, Inc., incorporated in January 1992, is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company�� primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants. The Urgent PC system is a United States Food and Drug Administration (FDA)-approved minimally invasive, office-based neuromodulation therapy for the treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique Implants a urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency (ISD). Outside of the United States, the Company�� Urgent PC is also approved for treatment of fecal incontinence, and Macroplastique is also approved for treatment of male stress incontinence and vesicoureteral reflux.

Urgent PC Neuromodulation System

Using a small-gauge needle electrode inserted above the ankle, the Urgent PC System delivers electrical impulses to the tibial nerve that travel to the sacral nerve plexus, a control center for pelvic floor and bladder function. Components of the Urgent PC system include a hair-width needle electrode, a lead set, and an external, handheld, battery-powered stimulator. For each 30-minute, office-based therapy session, the physician or other qualified healthcare provider inserts the needle electrode in the patient�� lower leg and connects the electrode to the stimulator. Typically, a patient undergoes 12 consecutive weekly treatment sessions, with follow-up maintenance treatments as required to sustain the therapeutic effect. The Company has received regulatory clearances for sale of the Urgent PC system in the United States, Canada and Europe. It also has launched its second generation Urgent PC system.

Macroplastique

Macroplastique is designed to restore the patient�� urinary contine! nce immediately following treatment. Macroplastique is a soft-textured, permanent implant injected, under endoscopic visualization, around the urethra distal to the bladder neck. It is a composition of heat vulcanized, solid, soft, irregularly shaped polydimethylsiloxane (solid silicone elastomer) implants suspended in a biocompatible excretable carrier gel. Macroplastique does not degrade, is not absorbed into surrounding tissues and does not migrate from the implant site. The Company has sold Macroplastique for several urological indications in over 40 countries outside the United States.

Other Uroplasty Products

The Company markets outside of the United States minimally invasive products to address fecal incontinence. Its PTQ Implants offer minimally invasive, soft-textured permanent implant for treatment of fecal incontinence. The PTQ Implants are implanted circumferentially into the submucosa of the anal canal, creating a bulking and supportive effect similar to that of Macroplastique injection for the treatment of stress urinary incontinence. The PTQ is Conformite Europeenne (CE) marked and is sold outside the United States in various international markets. The Urgent PC is also CE marked and sold outside of the United States for the treatment of fecal incontinence. In addition to urological applications, the Company markets its tissue bulking material outside the United States for otolaryngology vocal cord rehabilitation applications under the trade name VOX Implants. In the Netherlands and the United Kingdom only, the Company distributes certain wound care products in accordance with a distributor agreement.

The Company competes with Pfizer Inc., Johnson and Johnson, Novartis, Allergan, GlaxoSmithKline, Carbon Medical Technologies, BioForm, Inc., Q-Med AB and Contura.

Advisors' Opinion:

• [By Lisa Levin]

  Uroplasty (NASDAQ: UPI) shares reached a new 52-week high of $5.22 after the company reported strong Q3 results.

  Juniper Networks (NYSE: JNPR) shares gained 8.23% to touch a new 52-week high of $28.15 after the company reported better-than-expected fourth-quarter results. Barclays upgraded the stock from Equalweight to Overweight and lifted the price target from $29.00 to $34.00.

Top Performing Stocks To Watch For 2014: Legg Mason Inc. (LMI)

LMI Aerospace Inc. provides structural assemblies, kits and components, and design engineering services to the aerospace and defense markets in the United States. The company�s Aerostructures segment fabricates, machines, finishes, integrates, assembles, and kits machined and formed close tolerance aluminum, specialty alloy, composite components, and assemblies. Its products include wing slats and flap skins/components, and ailerons; winglet edges and modification kits; fuselage and wing skins; wing panels; helicopter cabin and aft section components; tail cone and edge assemblies; thrust reversers and engine nacelles/cowlings; door components, assemblies, and floor beams; cockpit window frames and landing light lens; and cockpit crew floor and bulkhead structure assemblies. This segment also provides wheel well and electronic rack assemblies; interior components; structural sheet metal, machined, milled, and extruded components; housings and assemblies; auxiliary power u nit components; fans and heat exchangers; ProWall engineered containers; and assemblies and components for rail yard switching equipment. Its Engineering Services segment offers engineering design, analysis, repair, certification, and program management services. This segment provides structural design and analysis services, including wing/wingbox, fixed and moveable leading edges/trailing edges, empennage, and tail cone design; winglet/wing mod design; nacelle, engine cowl, and thrust reverser design; weight improvement engineering; helicopter fuselage, cockpit, cabin frames, skins, longerons, and beams; and aircraft modification engineering services. It also offers systems design and integration, tool design and fabrication, manufacturing engineering, after-market engineering and support, aviation training system, and aviation maintenance engineering; and aviation system software engineering services. LMI Aerospace Inc. was founded in 1948 and is based in St. Charles, Miss ouri.

Advisors' Opinion:

• [By Sofia Horta e Costa]

  Lonmin Plc (LMI) jumped 2.8 percent to 295 pence, extending its biggest weekly rally in almost four months. Morgan Stanley upgraded the shares to overweight from equal weight, meaning that investors should buy more of the shares. The brokerage described their valuation as attractive.